These findings suggest that SHOX2, RASSF1A, and PTGER4 gene methylation could be valuable biomarkers for the early detection of LC, particularly in high-risk populations or those with atypical presentations. This evidence concerns the gene PTGER4 and laryngotracheoesophageal cleft.